Guggenheim > Rydex Series Funds
Health Care Fund
$23.84M
Avg Monthly Net Assets
$25.51M
Total Assets
$33K
Total Liabilities
$25.48M
Net Assets
Health Care Fund is a Mutual Fund in Rydex Series Funds
from Guggenheim,
based in Maryland,
United States of America.
The fund has four share classes
and monthly net assets of $23.84M.
On August 28th, 2024 it reported 119 holdings, the largest
being Eli Lilly & Co (3.8%), UnitedHealth Group Inc (3.0%) and Johnson & Johnson (2.5%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A | C000010620 | RYHEX | |
| Class C | C000010621 | RYHCX | |
| Class H | C000010619 | RYHAX | |
| Investor | C000010618 | RYHIX |
Holdings
From latest NPORT-P, filed August 28th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $463K | 4K | 1.82 |
| AbbVie, Inc. (AbbVie Inc) | Long | Equity-common | US | $608K | 4K | 2.38 |
| Acadia Healthcare Company, Inc. (Acadia Healthcare Co Inc) | Long | Equity-common | US | $86K | 1K | 0.34 |
| ACADIA Pharmaceuticals, Inc. (ACADIA Pharmaceuticals Inc) | Long | Equity-common | US | $50K | 3K | 0.20 |
| Agilent Technologies, Inc. (Agilent Technologies Inc) | Long | Equity-common | US | $212K | 2K | 0.83 |
| Align Technology, Inc. (Align Technology Inc) | Long | Equity-common | US | $134K | 557 | 0.53 |
| Alkermes plc | Long | Equity-common | US | $181K | 8K | 0.71 |
| Alnylam Pharmaceuticals, Inc. (Alnylam Pharmaceuticals Inc) | Long | Equity-common | US | $234K | 962 | 0.92 |
| Amgen, Inc. (Amgen Inc) | Long | Equity-common | US | $459K | 1K | 1.80 |
| Apellis Pharmaceuticals, Inc. (Apellis Pharmaceuticals Inc) | Long | Equity-common | US | $65K | 2K | 0.26 |
| Argenx SE | Long | Equity-common | NL | $200K | 464 | 0.78 |
| Arrowhead Pharmaceuticals, Inc. (Arrowhead Pharmaceuticals Inc) | Long | Equity-common | US | $61K | 2K | 0.24 |
| AstraZeneca plc | Long | Equity-common | GB | $296K | 4K | 1.16 |
| Avantor, Inc. (Avantor Inc) | Long | Equity-common | US | $129K | 6K | 0.50 |
| Axsome Therapeutics, Inc. (Axsome Therapeutics Inc) | Long | Equity-common | US | $65K | 808 | 0.26 |
| Azenta, Inc. (Azenta Inc) | Long | Equity-common | US | $57K | 1K | 0.22 |
| Baxter International, Inc. (Baxter International Inc) | Long | Equity-common | US | $143K | 4K | 0.56 |
| Becton Dickinson & Co. | Long | Equity-common | US | $287K | 1K | 1.12 |
| Bio-Techne Corp. | Long | Equity-common | US | $112K | 2K | 0.44 |
| Biogen, Inc. (Biogen Inc) | Long | Equity-common | US | $198K | 853 | 0.78 |
| BioMarin Pharmaceutical, Inc. (BioMarin Pharmaceutical Inc) | Long | Equity-common | US | $134K | 2K | 0.53 |
| Blueprint Medicines Corp. | Long | Equity-common | US | $75K | 695 | 0.29 |
| BofA Securities, Inc. | Long | Repurchase agreement | US | $63K | – | 0.25 |
| Boston Scientific Corp. | Long | Equity-common | US | $368K | 5K | 1.44 |
| Bridgebio Pharma, Inc. (Bridgebio Pharma Inc) | Long | Equity-common | US | $60K | 2K | 0.24 |
| Bristol-Myers Squibb Co. | Long | Equity-common | US | $321K | 8K | 1.26 |
| Bruker Corp. | Long | Equity-common | US | $88K | 1K | 0.35 |
| Cardinal Health, Inc. (Cardinal Health Inc) | Long | Equity-common | US | $168K | 2K | 0.66 |
| Catalent, Inc. (Catalent Inc) | Long | Equity-common | US | $109K | 2K | 0.43 |
| Cencora, Inc. (Cencora Inc) | Long | Equity-common | US | $212K | 942 | 0.83 |
| Centene Corp. | Long | Equity-common | US | $203K | 3K | 0.80 |
| Cigna Group (Cigna Group/The) | Long | Equity-common | US | $334K | 1K | 1.31 |
| Cooper Companies, Inc. (Cooper Cos Inc/The) | Long | Equity-common | US | $138K | 2K | 0.54 |
| CRISPR Therapeutics AG | Long | Equity-common | US | $148K | 3K | 0.58 |
| CVS Health Corp. | Long | Equity-common | US | $295K | 5K | 1.16 |
| Cytokinetics, Inc. (Cytokinetics Inc) | Long | Equity-common | US | $86K | 2K | 0.34 |
| Danaher Corp. | Long | Equity-common | US | $450K | 2K | 1.77 |
| DaVita, Inc. (DaVita Inc) | Long | Equity-common | US | $88K | 637 | 0.35 |
| Dentsply Sirona, Inc. (DENTSPLY SIRONA Inc) | Long | Equity-common | US | $76K | 3K | 0.30 |
| Dexcom, Inc. (Dexcom Inc) | Long | Equity-common | US | $232K | 2K | 0.91 |
| Edwards Lifesciences Corp. | Long | Equity-common | US | $264K | 3K | 1.04 |
| Elevance Health, Inc. (Elevance Health Inc) | Long | Equity-common | US | $392K | 724 | 1.54 |
| Eli Lilly & Co. | Long | Equity-common | US | $969K | 1K | 3.80 |
| Exact Sciences Corp. | Long | Equity-common | US | $96K | 2K | 0.38 |
| Exelixis, Inc. (Exelixis Inc) | Long | Equity-common | US | $88K | 4K | 0.35 |
| First American Government Obligations Fund - Class X (First American Funds) | Long | Short-term investment vehicle | US | $3K | 3K | 0.01 |
| GE HealthCare Technologies, Inc. (GE HealthCare Technologies Inc) | Long | Equity-common | US | $200K | 3K | 0.79 |
| Gilead Sciences, Inc. (Gilead Sciences Inc) | Long | Equity-common | US | $331K | 5K | 1.30 |
| GRAIL, Inc. (GRAIL Inc) | Long | Equity-common | US | $3K | 218.833 | 0.01 |
| GSK plc | Long | Equity-common | GB | $169K | 4K | 0.66 |
| Guardant Health, Inc. (Guardant Health Inc) | Long | Equity-common | US | $61K | 2K | 0.24 |
| Halozyme Therapeutics, Inc. (Halozyme Therapeutics Inc) | Long | Equity-common | US | $92K | 2K | 0.36 |
| HCA Healthcare, Inc. (HCA Healthcare Inc) | Long | Equity-common | US | $262K | 817 | 1.03 |
| HealthEquity, Inc. (HealthEquity Inc) | Long | Equity-common | US | $97K | 1K | 0.38 |
| Henry Schein, Inc. (Henry Schein Inc) | Long | Equity-common | US | $97K | 2K | 0.38 |
| Hologic, Inc. (Hologic Inc) | Long | Equity-common | US | $145K | 2K | 0.57 |
| Humana, Inc. (Humana Inc) | Long | Equity-common | US | $236K | 631 | 0.93 |
| ICON plc | Long | Equity-common | US | $215K | 686 | 0.84 |
| IDEXX Laboratories, Inc. (IDEXX Laboratories Inc) | Long | Equity-common | US | $217K | 446 | 0.85 |
| Illumina, Inc. (Illumina Inc) | Long | Equity-common | US | $136K | 1K | 0.54 |
| Inari Medical, Inc. (Inari Medical Inc) | Long | Equity-common | US | $56K | 1K | 0.22 |
| Incyte Corp. | Long | Equity-common | US | $115K | 2K | 0.45 |
| Inspire Medical Systems, Inc. (Inspire Medical Systems Inc) | Long | Equity-common | US | $46K | 340 | 0.18 |
| Insulet Corp. | Long | Equity-common | US | $130K | 642 | 0.51 |
| Intra-Cellular Therapies, Inc. (Intra-Cellular Therapies Inc) | Long | Equity-common | US | $90K | 1K | 0.35 |
| Intuitive Surgical, Inc. (Intuitive Surgical Inc) | Long | Equity-common | US | $443K | 995 | 1.74 |
| Ionis Pharmaceuticals, Inc. (Ionis Pharmaceuticals Inc) | Long | Equity-common | US | $92K | 2K | 0.36 |
| Iovance Biotherapeutics, Inc. (Iovance Biotherapeutics Inc) | Long | Equity-common | US | $49K | 6K | 0.19 |
| IQVIA Holdings, Inc. (IQVIA Holdings Inc) | Long | Equity-common | US | $211K | 997 | 0.83 |
| J.P. Morgan Securities LLC | Long | Repurchase agreement | US | $80K | – | 0.31 |
| Jazz Pharmaceuticals plc | Long | Equity-common | US | $85K | 793 | 0.33 |
| Johnson & Johnson | Long | Equity-common | US | $649K | 4K | 2.55 |
| Johnson & Johnson | Long | Rights | US | $0 | 752 | – |
| Labcorp Holdings, Inc. (Labcorp Holdings Inc) | Long | Equity-common | US | $147K | 720 | 0.58 |
| Lantheus Holdings, Inc. (Lantheus Holdings Inc) | Long | Equity-common | US | $81K | 1K | 0.32 |
| Madrigal Pharmaceuticals, Inc. (Madrigal Pharmaceuticals Inc) | Long | Equity-common | US | $48K | 173 | 0.19 |
| Masimo Corp. | Long | Equity-common | US | $83K | 662 | 0.33 |
| McKesson Corp. | Long | Equity-common | US | $296K | 506 | 1.16 |
| Medpace Holdings, Inc. (Medpace Holdings Inc) | Long | Equity-common | US | $103K | 251 | 0.41 |
| Medtronic plc | Long | Equity-common | US | $262K | 3K | 1.03 |
| Merck & Company, Inc. (Merck & Co Inc) | Long | Equity-common | US | $599K | 5K | 2.35 |
| Mettler-Toledo International, Inc. (Mettler-Toledo International I) | Long | Equity-common | US | $183K | 131 | 0.72 |
| Moderna, Inc. (Moderna Inc) | Long | Equity-common | US | $197K | 2K | 0.77 |
| Molina Healthcare, Inc. (Molina Healthcare Inc) | Long | Equity-common | US | $142K | 477 | 0.56 |
| Natera, Inc. (Natera Inc) | Long | Equity-common | US | $120K | 1K | 0.47 |
| Neurocrine Biosciences, Inc. (Neurocrine Biosciences Inc) | Long | Equity-common | US | $126K | 917 | 0.50 |
| Novartis AG | Long | Equity-common | CH | $182K | 2K | 0.71 |
| Novo Nordisk A/S | Long | Equity-common | DK | $231K | 2K | 0.90 |
| Option Care Health, Inc. (Option Care Health Inc) | Long | Equity-common | US | $76K | 3K | 0.30 |
| Penumbra, Inc. (Penumbra Inc) | Long | Equity-common | US | $88K | 491 | 0.35 |
| Pfizer, Inc. (Pfizer Inc) | Long | Equity-common | US | $438K | 16K | 1.72 |
| Quest Diagnostics, Inc. (Quest Diagnostics Inc) | Long | Equity-common | US | $134K | 977 | 0.52 |
| R1 RCM, Inc. (R1 RCM Inc) | Long | Equity-common | US | $49K | 4K | 0.19 |
| Regeneron Pharmaceuticals, Inc. (Regeneron Pharmaceuticals Inc) | Long | Equity-common | US | $369K | 351 | 1.45 |
| Repligen Corp. | Long | Equity-common | US | $92K | 733 | 0.36 |
| ResMed, Inc. (ResMed Inc) | Long | Equity-common | US | $173K | 902 | 0.68 |
| REVOLUTION Medicines, Inc. (REVOLUTION Medicines Inc) | Long | Equity-common | US | $83K | 2K | 0.33 |
| Roivant Sciences Ltd. | Long | Equity-common | US | $77K | 7K | 0.30 |
| Royalty Pharma plc | Long | Equity-common | US | $125K | 5K | 0.49 |
| Sarepta Therapeutics, Inc. (Sarepta Therapeutics Inc) | Long | Equity-common | US | $144K | 911 | 0.57 |
| Stryker Corp. | Long | Equity-common | US | $373K | 1K | 1.46 |
| Teladoc Health, Inc. (Teladoc Health Inc) | Long | Equity-common | US | $44K | 5K | 0.17 |
| Tenet Healthcare Corp. | Long | Equity-common | US | $120K | 902 | 0.47 |
| Teva Pharmaceutical Industries Ltd. | Long | Equity-common | IL | $165K | 10K | 0.65 |
| TG Therapeutics, Inc. (TG Therapeutics Inc) | Long | Equity-common | US | $56K | 3K | 0.22 |
| Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific Inc) | Long | Equity-common | US | $494K | 893 | 1.94 |
| Ultragenyx Pharmaceutical, Inc. (Ultragenyx Pharmaceutical Inc) | Long | Equity-common | US | $60K | 1K | 0.24 |
| United Therapeutics Corp. | Long | Equity-common | US | $134K | 422 | 0.53 |
| UnitedHealth Group, Inc. (UnitedHealth Group Inc) | Long | Equity-common | US | $763K | 1K | 3.00 |
| Universal Health Services, Inc. (Universal Health Services Inc) | Long | Equity-common | US | $118K | 637 | 0.46 |
| Vaxcyte, Inc. (Vaxcyte Inc) | Long | Equity-common | US | $92K | 1K | 0.36 |
| Veeva Systems, Inc. (Veeva Systems Inc) | Long | Equity-common | US | $176K | 962 | 0.69 |
| Vertex Pharmaceuticals, Inc. (Vertex Pharmaceuticals Inc) | Long | Equity-common | US | $372K | 793 | 1.46 |
| Viatris, Inc. (Viatris Inc) | Long | Equity-common | US | $124K | 12K | 0.49 |
| Viking Therapeutics, Inc. (Viking Therapeutics Inc) | Long | Equity-common | US | $81K | 2K | 0.32 |
| Waters Corp. | Long | Equity-common | US | $143K | 493 | 0.56 |
| West Pharmaceutical Services, Inc. (West Pharmaceutical Services I) | Long | Equity-common | US | $166K | 504 | 0.65 |
| Zimmer Biomet Holdings, Inc. (Zimmer Biomet Holdings Inc) | Long | Equity-common | US | $165K | 2K | 0.65 |
| Zoetis, Inc. (Zoetis Inc) | Long | Equity-common | US | $298K | 2K | 1.17 |
Address
Rydex Series Funds
702 King Farm Blvd., Suite 200
Rockville
Maryland
20850
United States of America
Directors
Amy J. Lee
Angela Brock-Kyle
Randall C. Barnes
Ronald A. Nyberg
Ronald E. Toupin, Jr.
Sandra G. Sponem
Thomas F. Lydon Jr.
Transfer Agents
MUFG Investor Services (US), LLC
Pricing Services
ICE Data Services
Custodians
U.S. Bank N.A.
Shareholder Servicing Agents
MUFG Investor Services (US), LLC
Admins
MUFG Investor Services (US), LLC
Brokers
Instinet, LLC
BARCLAYS CAPITAL INC.
BTIG, LLC
BOFA SECURITIES, INC.